Biovail news

Teva, Impax Plan Generic Wellbutrin XL Study >TEVA IPXL BVF

Wall Street Journal - 10 minutes ago
By Andy Georgiades Of DOW JONES NEWSWIRES TORONTO (Dow Jones)--Teva Pharmaceutical Industries Ltd. (TEVA) and Impax Laboratories Inc. (IPXL) will conduct a landmark clinical study of their generic ...

Alkermes, Inc. Meets Analyst Expectations; ALKS, ACUR, BVF

Biovail Corp reports USD0.09 dividend

Trading Markets - 15 minutes ago
Nov 06, 2009 (M2 EQUITYBITES via COMTEX) -- BVF -- The board of directors of pharmaceutical company Biovail Corporation (NYSE:BVF) (TSX:BVF) declared on Thursday a quarterly cash dividend of USD0 ...

Biovail to focus on ready products, CEO says

Biovail stock slips on drug's clinical trial

Canadian Press - 13 minutes ago
Canadian pharmaceutical company Biovail Corp. stock slipped in early trading Tuesday after the company reported disappointing results from a key clinical trial of a new Parkinson's disease drug ...

BRIEF-Biovail eyeing 10 to 20 merger or licensing deals

Interactive Investor - 2 minutes ago
Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. Registered Office: Standon House, 21 Mansell Street ...

Biovail Corporation Beats Analyst Expectations; BVF, NKTR, FLML

Biovail Corporation Declares Quarterly Dividend

Reuters Key Development - 1 hour ago

Biovail Declares Quarterly Dividend

Business Wire - 5 minutes ago
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company's Board of Directors has declared a quarterly cash dividend of US$0.09 per share payable on ...

Looking ahead to Biovail Corporation earnings; BVF, HSP, ELN